Skip to content

Efficacy of Ozone Therapy on Allergic Rhinitis

Comparison of Efficacy of Ozone Therapy with Routine Medical Treatment On The Severity Of Allergic Rhinitis.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171105037262N2
Enrollment
40
Registered
2017-12-01
Start date
2017-12-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Allergic rhinitis due to pollen

Interventions

Intervention 1: Intervention group: Patients in this group, in addition to the medical treatment, will benefit from minor autohemotherapy with appropriate dosage and injection intervals and standard p
Treatment - Drugs
Intervention group: Patients in this group, in addition to the medical treatment, will benefit from minor autohemotherapy with appropriate dosage and injection intervals and standard protocol.

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: Having Allergic Rhinitis Age over 12 years

Exclusion criteria

Exclusion criteria: Any Respiratory and non-respiratory inflammation such as infection Recent Massive Surgery Severe Pulmonary or Renal Disease Alcohol Abuse Sever Addiction Uncontrolled Diabetes Cancer Autoimmune diseases

Design outcomes

Primary

MeasureTime frame
Disease severity. Timepoint: At the beginning of the intervention. Method of measurement: Questionnaire.;IgE. Timepoint: At the beginning of the intervention. Method of measurement: ELISA.

Secondary

MeasureTime frame
Disease severity. Timepoint: 12weeks after intervention. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Nikoueinejad

Bagheiat-allah University of Medical Sciences

hnikuinejad@yahoo.com+98 31 5554 2999

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026